Role of leptin receptor gene polymorphisms in susceptibility to the development of essential hypertension: A case-control association study in a Northern Han Chinese population

Journal of Human Hypertension

Volumn 28, Issue 9, 2014, Pages 551-556

  Liu, Y ^a   Lou, Y Q ^a,b   Liu, K ^c   Liu, J L ^a   Wang, Z G ^a   Wen, J ^a   Zhao, Q ^d,e   Wen, S J ^a   Xiao, L ^e  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c CHINA MEITAN GENERAL HOSPITAL   (China)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chinese; essential hypertension; haplotypes; leptin receptor; linkage disequilibrium; polymorphism

Indexed keywords

ARGININE; ASPARAGINE; GLUTAMINE; LEPTIN RECEPTOR; LYSINE; LEPTIN RECEPTOR, HUMAN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOMINANT GENE; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HAN CHINESE; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHINA; EPIDEMIOLOGY; ETHNOLOGY; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, LEPTIN; RISK ASSESSMENT; RISK FACTORS;

EID: 84906316186     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.149     Document Type: Article

References (37)

1. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40(6): 920-927.
2. Muy-Rivera M, Ning Y, Frederic IO, Vadachkoria S, Luthy DA, Williams MA. Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk. Physiol Res 2005; 54(2): 167-174.
3. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M et al. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995; 44(7): 855-858.
4. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002; 26(11): 1407-1433.
5. Grassi G. Leptin, sympathetic nervous system, and baroreflex function. Curr Hypertens Rep 2004; 6(3): 236-240.
6. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45(1): 9-14.
7. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392(6674): 398-401.
8. Pasman WJ, Westerterp-Plantenga MS, Saris WH. The effect of exercise training on leptin levels in obese males. Am J Physiol 1998; 274(2 Pt 1): E280-E286.
9. Wiedemann A, Vocke F, Fitzgerald JS, Markert UR, Jeschke U, Lohse P et al. Leptin gene (TTTC)(n) microsatellite polymorphism as well as leptin receptor R223Q and PPARgamma2 P12A substitutions are not associated with hypertensive disorders in pregnancy. Am J Reprod Immunol 2010; 63(4): 310-317.
10. Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K et al. Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab 2000; 85(9): 3126-3131.
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206-1252.
12. Gu D, Su S, Ge D, Chen S, Huang J, Li B et al. Association study with 33 singlenucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 2006; 47(6): 1147-1154.
13. Ge D, Huang J, He J, Li B, Duan X, Chen R et al. beta2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese. Ann Hum Genet 2005; 69(Pt 1): 36-44.
14. Lou Y, Liu J, Li Y, Liu Y, Wang Z, Liu K et al. Association study of the beta2- adrenergic receptor gene polymorphisms and hypertension in the northern Han Chinese. PLoS One 2011; 6(4): e18590.
15. Wang Z, Liu Y, Liu J, Liu K, Lou Y, Wen J et al. E-selectin gene polymorphisms are associated with essential hypertension: a case-control pilot study in a Chinese population. BMC Med Genet 2010; 11: 127.
16. Dupont WD, Plummer Jr WD. Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 11(2): 116-128.
17. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21(2): 263-265.
18. Qin ZS, Niu T, Liu JS. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 2002; 71(5): 1242-1247.
19. Liu K, Liu J, Huang Y, Liu Y, Lou Y, Wang Z et al. Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls. PLoS One 2010; 5(9): pii: e13057.
20. Gu P, Jiang W, Chen M, Lu B, Shao J, Du H et al. Association of leptin receptor gene polymorphisms and essential hypertension in a Chinese population. J Endocrinol Invest 2012; 35(9): 859-865.
21. Wen B, Li H, Lu D, Song X, Zhang F, He Y et al. Genetic evidence supports demic diffusion of Han culture. Nature 2004; 431(7006): 302-305.
22. Zhang HG, Chen YF, Ding M, Jin L, Case DT, Jiao YP et al. Dermatoglyphics from all Chinese ethnic groups reveal geographic patterning. PLoS One 2010; 5(1): e8783.
23. Tsuruta M, Adachi H, Hirai Y, Fujiura Y, Imaizumi T. Association between alcohol intake and development of hypertension in Japanese normotensive men: 12-year follow-up study. Am J Hypertens 2000; 13(5 Pt 1): 482-487.
24. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Battistelli M et al. Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension. J Hypertens 1995; 13(10): 1209-1215.
25. de Luis Roman D, de la Fuente RA, Sagrado MG, Izaola O, Vicente RC. Leptin receptor Lys656Asn polymorphism is associated with decreased leptin response and weight loss secondary to a lifestyle modification in obese patients. Arch Med Res 2006; 37(7): 854-859.
26. Masuo K, Straznicky NE, Lambert GW, Katsuya T, Sugimoto K, Rakugi H et al. Leptin-receptor polymorphisms relate to obesity through blunted leptinmediated sympathetic nerve activation in a Caucasian male population. Hypertens Res 2008; 31(6): 1093-1100.
27. Bender N, Allemann N, Marek D, Vollenweider P, Waeber G, Mooser V et al. Association between variants of the leptin receptor gene (LEPR) and overweight: a systematic review and an analysis of the CoLaus study. PLoS One 2011; 6(10): e26157.
28. Qu Y, Yang Z, Jin F, Sun L, Feng J, Tang L et al. The haplotype identified in LEPR gene is associated with type 2 diabetes mellitus in northern Chinese. Diabetes Res Clin Pract 2008; 81(1): 33-37.
29. Mackey-Lawrence NM, Guo X, Sturdevant DE, Virtaneva K, Hernandez MM, Houpt E et al. Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica. Infect Immun 2013; 81(5): 1460-1470.
30. Riestra P, Garcia-Anguita A, Torres-Cantero A, Bayonas MJ, de Oya M, Garces C. Association of the Q223R polymorphism with age at menarche in the leptin receptor gene in humans. Biol Reprod 2011; 84(4): 752-755.
31. Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H et al. Molecular cloning of rat leptin receptor isoform complementary DNAs - identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 1996; 225(1): 75-83.
32. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996; 13(1): 18-19.
33. Knudson JD, Dincer UD, Zhang C, Swafford Jr AN, Koshida R, Picchi A et al. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289(1): H48-H56.
34. Knudson JD, Payne GA, Borbouse L, Tune JD. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep 2008; 10(6): 434-439.
35. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246(4): 409-418.
36. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104(25): 3052-3056.
37. Wang B, Fu E, Cao Y, Zhong Y, Fu G, Tian X et al. Effect of leptin receptor mutation on the development of chronic bronchitis. Asia Pac J Public Health 2013; 25(Suppl 4): 80S-87S.